Cinacalcet

Welcome to Dwaey, specifically on Cinacalcet page.
This medicine contains important and useful components, as it consists of
Cinacalcet is available in the market in concentration.

Generic Name of Cinacalcet - Learn More

Cinacalcet

Cinacalcet Precaution - What You Need to Know

Cinacalcet should be used with caution in specific populations, including pregnant or breastfeeding women, individuals with a history of certain medical conditions, and those undergoing long-term therapy. In pregnancy, Cinacalcet falls under category C, meaning its effects on the fetus are unknown, and it should only be used if the potential benefits outweigh the risks. It is also unclear whether Cinacalcet is excreted in breast milk, so its use during breastfeeding should be carefully considered based on the risk to the infant. For patients with a history of gastrointestinal bleeding, it should be used cautiously due to its potential to increase parathyroid hormone levels and cause hypocalcemia. Furthermore, monitoring of serum calcium levels is essential during therapy, especially for patients with chronic kidney disease or those undergoing dialysis, as low calcium levels can lead to severe complications like tetany and seizures. This drug can cause QT prolongation, so electrocardiogram (ECG) monitoring is recommended. In terms of misuse or dependency, Cinacalcet is not generally associated with misuse potential or addiction, though misuse of any drug may pose significant health risks.

Cinacalcet Indication - Uses and Benefits

Cinacalcet is primarily indicated for the treatment of hyperparathyroidism in patients with chronic kidney disease (CKD) on dialysis. It is also used to treat hypercalcemia associated with parathyroid carcinoma and primary hyperparathyroidism in patients who are not candidates for surgery. The drug works by lowering parathyroid hormone (PTH) levels, which can help prevent the complications associated with hyperparathyroidism, such as bone demineralization, fractures, and cardiovascular issues. Evidence-based guidelines recommend its use as part of a comprehensive approach to managing secondary hyperparathyroidism in CKD patients, particularly when calcium or vitamin D supplementation is insufficient. Off-label uses include its potential application in managing other types of hypercalcemia, such as in malignancy-related hypercalcemia, although the evidence for these uses is less robust. Clinical studies support its effectiveness in reducing serum calcium and improving bone mineral density in patients with conditions associated with excess PTH.

Cinacalcet Contraindications - Important Warnings

Cinacalcet is contraindicated in patients with known hypersensitivity to the drug or any of its components. It is also contraindicated in cases of hypocalcemia, as it can worsen the condition by further reducing calcium levels. Patients who have a history of severe liver disease should avoid using Cinacalcet, as hepatic metabolism plays a role in its clearance, and impaired liver function may lead to increased drug concentrations and toxicity. Additionally, it is contraindicated in patients with a known history of low calcium levels, as it may exacerbate hypocalcemia and lead to serious complications such as arrhythmias, muscle spasms, and tetany. Cinacalcet is not recommended for pediatric patients due to the lack of sufficient clinical data regarding its safety and efficacy in this group. It is important to carefully assess the patient's overall medical history, including calcium and phosphorus levels, before starting treatment.

Cinacalcet Side Effects - What to Expect

Common side effects of Cinacalcet include nausea, vomiting, diarrhea, and fatigue. These gastrointestinal symptoms typically occur during the early stages of therapy and may resolve with time. Severe side effects, though rare, include significant hypocalcemia, which can present with symptoms such as muscle cramps, tingling sensations, and even cardiac arrhythmias. Prolonged use or high doses can increase the risk of severe hypocalcemia, which may require immediate medical attention. Some patients may also experience dizziness or fainting due to changes in calcium and parathyroid hormone levels. In rare cases, Cinacalcet has been linked to seizures, especially in those with poor calcium control. Long-term use may also lead to changes in bone mineralization due to the altered calcium-phosphate balance. To mitigate side effects, it is important to monitor serum calcium levels regularly and adjust the dose as necessary. Patients should seek immediate medical attention if they experience severe symptoms such as muscle spasms, irregular heartbeats, or fainting.

Cinacalcet Pregnancy Category ID - Safety Information

3

Cinacalcet Mode of Action - How It Works

Cinacalcet is a calcimimetic agent, meaning it mimics the action of calcium on the calcium-sensing receptors (CaSR) located on the parathyroid gland. By binding to and activating these receptors, Cinacalcet reduces the secretion of parathyroid hormone (PTH), which in turn lowers calcium levels in the blood. This mechanism is particularly beneficial in conditions such as secondary hyperparathyroidism and hypercalcemia, where elevated PTH levels are causing abnormalities in calcium metabolism. The drug effectively decreases PTH secretion regardless of serum calcium concentrations, making it useful in patients with chronic kidney disease on dialysis, who often have dysregulated calcium and phosphate metabolism. Additionally, Cinacalcet influences the calcium balance by decreasing calcium reabsorption from bone, thereby reducing the risk of bone demineralization. It is rapidly absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 2-6 hours of oral administration. Its effects are dose-dependent, with higher doses more effectively reducing PTH levels, but also increasing the risk of hypocalcemia.

Cinacalcet Drug Interactions - What to Avoid

Cinacalcet has several important drug-drug interactions that should be carefully considered. It can increase the effects of drugs that also lower calcium levels, such as bisphosphonates, vitamin D analogs, and calcium-lowering agents, potentially leading to hypocalcemia. Co-administration with other drugs that affect the cytochrome P450 enzyme system, particularly CYP2D6, may alter the metabolism of Cinacalcet, resulting in either increased or decreased plasma concentrations. Common medications that interact with Cinacalcet include digoxin, which may have increased effects due to changes in calcium levels, and certain antifungal agents like ketoconazole that inhibit CYP enzymes. In terms of lifestyle interactions, alcohol consumption may exacerbate the drug's effects on the liver and calcium metabolism, although specific guidelines for alcohol use are not well-documented. Grapefruit juice can also affect drug metabolism by inhibiting certain enzymes involved in Cinacalcet’s clearance. To minimize adverse effects, it is advised that healthcare providers closely monitor patients for signs of hypocalcemia, especially when combining Cinacalcet with other agents affecting calcium or drug-metabolizing enzymes.

Cinacalcet Adult Dose - Recommended Dosage

For adults, the typical starting dose of Cinacalcet for managing secondary hyperparathyroidism in patients with chronic kidney disease on dialysis is 30 mg once daily. Depending on the patient’s response, the dose may be titrated every 2-4 weeks. The recommended dose range is typically 30-180 mg daily. For patients with parathyroid carcinoma or primary hyperparathyroidism who cannot undergo surgery, the initial dose is 30 mg daily, with gradual adjustments based on calcium and PTH levels. Cinacalcet should be taken with food to improve absorption. The maximum daily dose should not exceed 180 mg. In patients with comorbid conditions such as liver impairment or those on multiple medications, close monitoring is recommended, and the dose may need to be reduced to avoid adverse effects. Regular monitoring of serum calcium and PTH levels is essential to ensure that the therapeutic target is reached without causing hypocalcemia.

Cinacalcet Child Dose - Dosage for Children

Cinacalcet is not approved for pediatric use, and dosing guidelines for children are not well-established due to a lack of sufficient clinical data. However, there may be off-label uses in certain pediatric populations with secondary hyperparathyroidism, particularly in patients with chronic kidney disease who are on dialysis. In these cases, the drug should be prescribed cautiously and under the guidance of a pediatric nephrologist. Pediatric patients require close monitoring of calcium and PTH levels, and dosing should be adjusted to minimize the risk of hypocalcemia. Given the potential for severe side effects and lack of approved indications, Cinacalcet should only be considered for children when no other treatment options are available, and the benefits outweigh the risks.

Cinacalcet Renal Dose - Dosage for Kidney Conditions

For patients with chronic kidney disease, including those on dialysis, Cinacalcet is commonly prescribed. There is no need for a dose adjustment in patients with mild or moderate renal impairment, as the drug’s metabolism and elimination are minimally affected by kidney function. However, for patients on dialysis, regular monitoring of calcium, phosphorus, and PTH levels is essential to guide appropriate dosing. In cases of severe renal impairment without dialysis, the drug should be used with caution due to potential risks of elevated drug concentrations and hypocalcemia. Clinicians may need to reduce the dose or monitor renal function more frequently to ensure safety and efficacy during treatment.